DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carboplatin (Carboplatin) - Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neutropenia (217)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 217   Next >>

Possible Carboplatin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection

Drug(s) suspected as cause:
Carboplatin
    Dosage: 6 courses in high risk
    Indication: Retinoblastoma

Cyclophosphamide
    Indication: Retinoblastoma

Doxorubicin Hydrochloride
    Dosage: 4 courses in intermediate risk and 6 courses in high risk
    Indication: Retinoblastoma

Etoposide
    Indication: Retinoblastoma

Vincristine
    Dosage: 4 courses in intermediate risk and 6 courses in high risk
    Indication: Retinoblastoma

Other drugs received by patient: Neupogen



Possible Carboplatin side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)

Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 30 mg/m2 x 1/4 week
    Start date: 2011-03-16

Adriamycin PFS
    Dosage: 40 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Carboplatin
    Dosage: 250 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 350 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Etoposide
    Dosage: 100 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Prednisolone
    Dosage: 1mg/kg x 1/2 week
    Start date: 2011-12-13
    End date: 2011-12-14

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Start date: 2011-03-16

Prednisolone
    Dosage: 2 mg/m2, 1x/day
    Administration route: Oral
    Start date: 2011-03-24

Ranimustine
    Dosage: 60 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-16

Vincristine Sulfate
    Dosage: 1 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Vindesine Sulfate
    Dosage: 2.4 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium



Possible Carboplatin side effects in male

Reported by a physician from France on 2012-08-24

Patient: male

Reactions: Dermatitis Acneiform, Renal Failure, Neoplasm Malignant, Dehydration, Purpura, Neutropenia, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Dosage: 200 df, unknown/d
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-08-03

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Start date: 2012-08-17

Pemetrexed Disodium
    Dosage: 200 df, unknown/d
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-08-03



Possible Carboplatin side effects in female

Reported by a physician from Ireland on 2012-08-24

Patient: female, weighing 75.5 kg (166.1 pounds)

Reactions: Vomiting, Diarrhoea, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 790mg cyclic
    Indication: Breast Cancer
    Start date: 2012-08-09

Docetaxel
    Dosage: 75mgm2 cyclic
    Indication: Breast Cancer
    Start date: 2012-08-09

Lapatinib
    Dosage: 1000mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-08-09

Trastuzumab
    Dosage: 8mgk cyclic
    Indication: Breast Cancer
    Start date: 2012-08-09



Possible Carboplatin side effects in male

Reported by a physician from Hungary on 2012-08-22

Patient: male, weighing 74.0 kg (162.8 pounds)

Reactions: Pneumonia, Anaemia, Granulocytopenia, Neutropenia, Thrombocytopenia, Leukopenia, Infectious Pleural Effusion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: frequency: 1x, form infusion;
    Indication: non-Small Cell Lung Cancer

Avastin
    Dosage: frequency as per protocol, last dose of prior to event on 25 january 2010. form infusion

Avastin
    Dosage: last dose prior to sae: 16 february 2010. last dose prior to leukopenia was 23 mar 2010

Avastin
    Dosage: last dose prior to sae: 16 february 2010,infusion, frequency: 1xdaily

Carboplatin
    Dosage: last dose prior to event on 25 january 2010.

Carboplatin
    Dosage: form: infusion;
    Indication: non-Small Cell Lung Cancer

Carboplatin
    Dosage: last dose prior to sae: 23 march 2010, frequency: 1xdaily

Carboplatin

Gemcitabine Hydrochloride
    Dosage: last dose prior to sae: 01 april 2010

Gemcitabine Hydrochloride

Gemcitabine Hydrochloride
    Dosage: freq: day 1 + 8 every 3 weeks

Gemcitabine Hydrochloride
    Dosage: last dose of iv gemcitabine prior to event on 25 january 2010.

Gemcitabine Hydrochloride
    Dosage: freq: day 1 + 8 every 3 weeks

Gemcitabine Hydrochloride
    Dosage: form infusion, on day 1 and day 8; frequency: 1xdaily;
    Indication: non-Small Cell Lung Cancer
    Start date: 2009-11-09
    End date: 2009-11-17

Gemcitabine Hydrochloride
    Dosage: frequency: 2xevery three week, form: infusion

Other drugs received by patient: Fluticasone Propionate / Salmeterol; Augmentin '500'; Kalium-R; Sinecod; Ondansetron; Bisoprolol Fumarate; Pegfilgrastim; Lidocaine; Ciprofloxacin Hydrochloride; Neupogen; Spiriva; Kalium-R; Eprex; Neorecormon; Hydromorphone HCL; Berodual; Fluticasone Propionate / Salmeterol; Neorecormon; Augmentin '500'; Kalium-R; Medrol; Medrol; Neupogen; Medrol; Bisoprolol Fumarate; Spiriva; Megesin; Megesin



Possible Carboplatin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient:

Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection

Drug(s) suspected as cause:
Carboplatin
    Dosage: 6 courses in high risk
    Indication: Retinoblastoma

Cyclophosphamide
    Indication: Retinoblastoma

Doxorubicin HCL
    Dosage: 4 courses in intermediate risk and 6 courses in high risk
    Indication: Retinoblastoma

Etoposide
    Indication: Retinoblastoma

Vincristine
    Dosage: 4 courses in intermediate risk and 6 courses in high risk
    Indication: Retinoblastoma

Other drugs received by patient: Neupogen



Possible Carboplatin side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-21

Patient: , weighing 61.4 kg (135.1 pounds)

Reactions: Neutropenia, Enterocolitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 2150 mg
    Start date: 2012-07-13

Cyclophosphamide
    Dosage: 1000 mg
    Start date: 2012-08-09

Doxorubicin Hydrochloride
    Dosage: 100 mg
    Start date: 2012-08-09

Taxol
    Dosage: 1242 mg
    Start date: 2012-08-03



Possible Carboplatin side effects in 65 year old female

Reported by a physician from Germany on 2012-08-20

Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)

Reactions: Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: dose reduced
    Start date: 2010-06-15
    End date: 2010-07-22

Carboplatin
    Dosage: form: vialsdose level: 5 auc
    Start date: 2010-05-04

Docetaxel
    Dosage: dose: 60mg/m2, form:vials
    Start date: 2010-05-04

Docetaxel
    Dosage: dose reduced, form:vials
    Start date: 2010-06-15
    End date: 2010-07-22

Trastuzumab
    Dosage: dose level: 6mg/kgform: vials
    Start date: 2010-05-04
    End date: 2010-07-22

Other drugs received by patient: Metoclopramide; Bisoprolol Fumarate; Ondansetron; Dexamethasone; Emend; Loperamide



Possible Carboplatin side effects in 77 year old male

Reported by a physician from United States on 2012-08-08

Patient: 77 year old male, weighing 66.6 kg (146.5 pounds)

Reactions: Pneumonia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: date of last dos prior to sae: 13/feb/2012,
    Indication: Neoplasm

Carboplatin
    Dosage: last dose: 648 mg, date of last dos prior to sae:13/feb/2012, last dose: 03/apr/2012
    Indication: Neoplasm

GDC-0980 (Pi3k / Mtor Inhibitor)
    Dosage: last dose: 25 mg, date of last dose prior to sae 5/apr/2012
    Administration route: Oral
    Indication: Neoplasm

Paclitaxel
    Dosage: last dose: 360 mg, date of last dose prior to sae: 13/feb/2012, last dose: 05/apr/2012
    Indication: Neoplasm

Other drugs received by patient: Ondansetron; Naproxen (Aleve); Zantac; Milk OF Magnesia TAB; Acyclovir; Restoril; Imodium; Ondansetron; Plavix; Dicyclomine



Possible Carboplatin side effects in female

Reported by a physician from United States on 2012-08-01

Patient: female, weighing 136.5 kg (300.3 pounds)

Reactions: Neutropenia

Drug(s) suspected as cause:
Carboplatin
    Dosage: 872 mg

Taxol
    Dosage: 350 mg



Possible Carboplatin side effects in 65 year old female

Reported by a physician from Germany on 2012-08-01

Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)

Reactions: Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: form: vialsdose level: 5 auc
    Start date: 2010-05-04

Carboplatin
    Dosage: dose reduced
    Start date: 2010-06-15
    End date: 2010-07-22

Docetaxel
    Dosage: dose: 60mg/m2
    Start date: 2010-05-04

Docetaxel
    Dosage: dose reduced
    Start date: 2010-06-15
    End date: 2010-07-22

Trastuzumab
    Dosage: dose level: 6mg/kgform: vials
    Start date: 2010-05-04
    End date: 2010-07-22

Other drugs received by patient: Metoclopramide; Ondansetron; Emend; Bisoprolol Fumarate; Dexamethasone; Loperamide



Possible Carboplatin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient: female

Reactions: Hypophosphataemia, Fatigue, Tinnitus, Clostridium Difficile Colitis, Neutropenia, Thrombocytopenia, Klebsiella Bacteraemia

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Ovarian Cancer

Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Malignant Peritoneal Neoplasm

Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
    Indication: Ovarian Cancer

Paclitaxel
    Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
    Indication: Ovarian Cancer



Possible Carboplatin side effects in male

Reported by a physician from United States on 2012-07-23

Patient: male, weighing 84.0 kg (184.8 pounds)

Reactions: White Blood Cell Count Decreased, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 1293 mg
    End date: 2011-02-10

Paclitaxel
    Dosage: 760 mg
    End date: 2011-02-10

Other drugs received by patient: ...



Possible Carboplatin side effects in male

Reported by a physician from United States on 2012-07-23

Patient: male, weighing 84.1 kg (185.0 pounds)

Reactions: White Blood Cell Count Decreased, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 1294 mg
    End date: 2010-12-30

Paclitaxel
    Dosage: 760 mg
    End date: 2010-12-30



Possible Carboplatin side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-17

Patient: 58 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Oropharyngeal Pain, Neutropenia, Radiation Mucositis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Dosage: 1df auc =5, dose redused to auc 3.
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Gemcitabine Hydrochloride
    Dosage: last dose on:11jun12 dose redused to:500mg/m2
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Ramucirumab
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Other drugs received by patient: Prilosec; Ondansetron; Neupogen; Methadone HCL; Levaquin; Roxanol; Zometa; Promethazine; Warfarin Sodium; Platelets



Possible Carboplatin side effects in 76 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-17

Patient: 76 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Hypotension, Disseminated Intravascular Coagulation, Headache, Malaise, Sepsis, Neutropenia, Cardiac Arrest, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Dosage: dose unit: unknown
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2010-10-04
    End date: 2010-10-04

Etoposide
    Dosage: dose unit: unknown
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2010-10-04
    End date: 2010-10-06

Other drugs received by patient: Aldactone; Urief; Warfarin Sodium; Alendronate Sodium; Spiriva; Magnesium Oxide; Theophylline; Ambroxol Hydrochloride; Enalapril Maleate; Seltepnon; Vasolator; Sotalol Hydrochloride



Possible Carboplatin side effects in female

Reported by a physician from China on 2012-07-17

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Suicide Attempt, Neutropenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Avastin
    Dosage: last dose: 21 jul 2010
    Indication: Breast Cancer
    Start date: 2010-03-16
    End date: 2010-08-30

Carboplatin
    Dosage: last dose: 30 jun 2010
    Indication: Breast Cancer
    Start date: 2010-03-16

Clonazepam
    Indication: Product Used FOR Unknown Indication

Docetaxel
    Dosage: last dose: 30 jun 2010
    Indication: Breast Cancer
    Start date: 2010-03-16

Herceptin
    Dosage: last dose: 21 jul 2010
    Indication: Breast Cancer
    Start date: 2010-03-16
    End date: 2010-08-30



Possible Carboplatin side effects in 64 year old female

Reported by a physician from France on 2012-07-16

Patient: 64 year old female, weighing 54.0 kg (118.8 pounds)

Reactions: Muscle Atrophy, Neutropenia, Polyarthritis, Thrombocytopenia, Paraesthesia

Drug(s) suspected as cause:
Carboplatin
    Indication: Bronchial Carcinoma
    End date: 2011-06-01

Taxotere
    Dosage: dose: 4 cycles at 120 mg every 3 weeks
    Indication: Bronchial Carcinoma
    Start date: 2011-03-28
    End date: 2011-06-03



Possible Carboplatin side effects in 59 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 59 year old female, weighing 58.9 kg (129.6 pounds)

Reactions: Otitis Externa, Skin Hyperpigmentation, Hypoacusis, Neuropathy Peripheral, Diarrhoea, Ear Pain, Otitis Media, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 128 mg iv, 118 mg iv
    Indication: Chemotherapy
    Start date: 2012-04-17
    End date: 2012-06-26

Carboplatin
    Dosage: 720 mg
    Indication: Chemotherapy
    Start date: 2012-04-17
    End date: 2012-06-26

Other drugs received by patient: Zofren 8 MG; Atenolol; Neurontin



Possible Carboplatin side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-13

Patient: male

Reactions: Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Haemolysis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in male

Reported by a physician from Japan on 2012-07-12

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Nasopharyngitis, Rash, Eczema, Pruritus Generalised, Colonic Polyp, Interstitial Lung Disease, Insomnia, Bone Marrow Failure, Neutropenia, Neutrophil Count Decreased, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Start date: 2012-03-15
    End date: 2012-03-15

Avastin
    Start date: 2012-02-01
    End date: 2012-02-01

Avastin
    Indication: Lung Adenocarcinoma Metastatic
    Start date: 2011-12-28
    End date: 2011-12-28

Carboplatin
    Start date: 2012-03-15
    End date: 2012-03-15

Carboplatin
    Indication: Lung Adenocarcinoma Metastatic
    Start date: 2012-02-01
    End date: 2012-02-01

Paclitaxel
    Indication: Lung Adenocarcinoma Metastatic
    Start date: 2012-03-15
    End date: 2012-04-12

Sulbacilline
    Indication: Interstitial Lung Disease
    Start date: 2012-05-02
    End date: 2012-05-09

Other drugs received by patient: Loxoprofen; Famotidine; Dexamethasone Sodium Phosphate; Restamin; Granisetron; Diclofenac Sodium; Sennoside; Vitamedin; Rebamipide; Zofran



Possible Carboplatin side effects in male

Reported by a physician from Italy on 2012-07-11

Patient: male

Reactions: Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Haemolysis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in male

Reported by a physician from United States on 2012-07-10

Patient: male, weighing 84.1 kg (185.0 pounds)

Reactions: White Blood Cell Count Decreased, Neutropenia

Drug(s) suspected as cause:
Carboplatin
    Dosage: 1292 mg
    End date: 2011-02-10

Erbitux
    Dosage: 2880 mg
    End date: 2011-02-24

Paclitaxel
    Dosage: 760 mg
    End date: 2011-02-10



Possible Carboplatin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-09

Patient: female, weighing 136.5 kg (300.3 pounds)

Reactions: Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 872 mg

Paclitaxel
    Dosage: 350 mg



Possible Carboplatin side effects in 72 year old female

Reported by a physician from Israel on 2012-07-06

Patient: 72 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Multi-Organ Failure, Urosepsis, Blood Pressure Abnormal, Neutropenia, Myocardial Infarction, Heart Rate Abnormal, Cerebral Haemorrhage

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab

Bevacizumab
    Dosage: total dose 828 mg
    Start date: 2010-07-28
    End date: 2010-07-28

Bevacizumab
    Dosage: total dose 828 mg
    Start date: 2010-10-25
    End date: 2010-10-25

Carboplatin
    Dosage: form: vialdose level: 5 auc
    Start date: 2010-10-25
    End date: 2010-10-25

Carboplatin
    Dosage: form: vialdose level: 5 auc
    Start date: 2010-07-28
    End date: 2010-07-28

Carboplatin

Docetaxel
    Dosage: form: vialdose level: 75 mg/m2
    Start date: 2010-10-25
    End date: 2010-10-25

Docetaxel
    Dosage: form: vialdose level: 75 mg/m2
    Start date: 2010-07-28
    End date: 2010-07-28

Docetaxel

Trastuzumab
    Start date: 2010-07-28
    End date: 2010-07-28

Trastuzumab
    Dosage: dose level:6 mg/kg
    Start date: 2010-10-25
    End date: 2010-10-25

Trastuzumab

Other drugs received by patient: Omeprazole; Bondormin; Micropirin; Simvastatin; Citalopram Hydrobromide; Ramipril; Disothiazide



Possible Carboplatin side effects in male

Reported by a physician from United States on 2012-07-05

Patient: male, weighing 64.7 kg (142.3 pounds)

Reactions: Radiation Mucositis, Neutropenia, Oropharyngeal Pain

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Carboplatin
    Dosage: unk, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04
    End date: 2012-06-04

Carboplatin
    Dosage: 3 df, other

Gemcitabine Hydrochloride
    Dosage: 500 mg/m2, other

Gemcitabine Hydrochloride
    Dosage: 1000 mg/m2, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04
    End date: 2012-06-11

Ramucirumab (1121b) (Ly3009806)
    Dosage: 10 mg/kg, other
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-06-04

Other drugs received by patient: Ondansetron; Levaquin; Prilosec; Roxanol; Promethazine; Zometa; Hydrocodone Bitartrate; Warfarin Sodium; Methadon HCL TAB; Platelets; Neupogen; Promethazine



Possible Carboplatin side effects in 32 year old male

Reported by a consumer/non-health professional from Italy on 2012-06-28

Patient: 32 year old male

Reactions: Vomiting, Alopecia, Neutropenia, Asthenia

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Testicular Seminoma (Pure)
    Start date: 2011-09-16
    End date: 2011-12-10

Carboplatin
    Indication: Testis Cancer
    Start date: 2011-09-23
    End date: 2011-12-10

Cisplatin
    Indication: Testicular Seminoma (Pure)
    Start date: 2011-09-16
    End date: 2011-12-10

Vepesid
    Indication: Testicular Seminoma (Pure)
    Start date: 2011-09-16
    End date: 2011-12-10



Possible Carboplatin side effects in female

Reported by a consumer/non-health professional from Italy on 2012-06-27

Patient: female

Reactions: Respiratory Failure, Neutropenia, Thrombocytopenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in 65 year old female

Reported by a physician from Germany on 2012-06-20

Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)

Reactions: Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: form: vialsdose level: 5 auc
    Start date: 2010-05-04

Carboplatin
    Dosage: dose reduced
    Start date: 2010-06-15
    End date: 2010-07-22

Docetaxel
    Dosage: dose: 60mg/m2
    Start date: 2010-05-04

Docetaxel
    Dosage: dose reduced
    Start date: 2010-06-15
    End date: 2010-07-22

Trastuzumab
    Dosage: dose level: 6mg/kgform: vials
    Start date: 2010-05-04
    End date: 2010-07-22

Other drugs received by patient: Metoclopramide; Bisoprolol Fumarate; Emend; Dexamethasone; Ondansetron; Loperamide



Possible Carboplatin side effects in 76 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18

Patient: 76 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Malaise, Hypotension, Disseminated Intravascular Coagulation, Neutropenia, Headache, Thrombocytopenia, Cardiac Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Dosage: dose unit: unknown
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2010-10-04
    End date: 2010-10-04

Etoposide
    Dosage: dose unit: unknown
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2010-10-04
    End date: 2010-10-06

Other drugs received by patient: Sotalol Hydrochloride; Ambroxol Hydrochloride; Seltepnon; Enalapril Maleate; Magnesium Oxide; Carvedilol; Alendronate Sodium; Spiriva; Furosemide; Warfarin Sodium; Theophylline; Aldactone; Urief; Vasolator



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017